US FDA panel 'TIPs' in favor of Novartis' easier-to-use tobramycin
20:50 EDT 5 Sep 2012 | SCRIP
In a 13-1 vote, the US FDA's Anti-Infective Drugs Advisory Committee on 5 September said Novartis demonstrated adequate evidence of efficacy and safety to support the use of its new inhalation powder form of tobramycin, known as TIP, in managing.....
Original Article: US FDA panel 'TIPs' in favor of Novartis' easier-to-use tobramycin
More From BioPortfolio on "US FDA panel 'TIPs' in favor of Novartis' easier-to-use tobramycin"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
